PhD Student Position on Pancreatic Organoids: A fully funded PhD opportunity is available at the University of Twente for ambitious researchers interested in advancing the field of tissue engineering and regenerative medicine through innovative microfluidic technologies.
PhD Student Position on Mass Production of Pancreatic Organoids
Designation
PhD Student Position
Table of Information
| Category | Details |
|---|---|
| Research Area | Mass production of pancreatic organoids using microfluidic micromaterials |
| Location | University of Twente, Netherlands |
| Salary | €3,059 – €3,881 gross monthly, based on tenure |
| Hours | 38 – 40 hours per week |
| Deadline | 31st January 2026 |
Eligibility/Qualification
- Master’s degree in Biomedical Engineering, Materials Science, Biomedical Sciences, or an equivalent field.
- Strong analytical, problem-solving skills, and a keen interest in microfluidic technology, biomaterials, and biofabrication.
- Experience in microengineering, material synthesis, characterization, and relevant techniques is advantageous.
- Excellent communication skills in English, both written and spoken.
- Enjoyment of teamwork in interdisciplinary research settings.
Description
In this position, you will work at the Leijten Laboratory, where you will develop functional pancreatic tissues. The research will focus on using iPSCs and organoid-forming micromaterials within advanced microfluidic devices to create immunoprotective hydrogel microcapsules. You will explore ways to improve organoid formation and undertake innovative techniques like volumetric 3D bioprinting. The skill set developed in this role will encompass tissue engineering, bioink development, and scientific publication writing.
How to Apply
Interested candidates should apply by submitting their CV, a motivation letter, and a list of publications via the “Apply Now” button on the University of Twente’s website.
Last Date for Apply
31st January 2026
This position is an exceptional opportunity for those keen to impact healthcare positively through cutting-edge research and innovation.
